Abbott Laboratories Com Stk NPV (NYSE:ABT)

CAPS Rating: 5 out of 5

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.


Player Avatar EVplusEV (57.43) Submitted: 11/12/2012 12:54:31 PM : Outperform Start Price: $31.11 ABT Score: +0.15

Catalyst #1: ABT presenting at the American Association for the Study of Liver Diseases today, look for positive reports on its Hep C program. Catalyst #2: Splitting into two companies sometime after the first of the year; one pharma and one medical technology. Stock is down over 9% from the highs and with these catalysts, I'm in this on a trade with a target of $71 per share.

Featured Broker Partners